Privatlivspræferencer
Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.
  • Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • ShortsalgSe hvilke børsnoterede selskaber der har offentliggjorte korte positioner
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Prevas: Likely near the bottom, but not there yet - ABG

PREV BEksterne analyser19.10.2026, 14.31

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier

Download analyse (PDF)
* Demand stabilising, but reduction in FTEs a headwind
* We cut adj. EBITA by 6% for '26e and 10% for '27e
* Trading at historical lows, 40% below Nordic peers


Stabilising, but no recovery yet

The market remains weak but is stabilising, and the latest data from the National Institute of Economic Research show improving demand for technical consultants. However, the lower number of FTEs means fewer billable hours, and we therefore expect an organic decline of 1.7%. Growth should be supported by continued strong demand in defence and some pick-up in the life science market in Denmark following years of slow market growth. With fewer FTEs, we expect utilisation to increase as demand picks up, which should in theory lift margins. However, Nordic salaries typically increase by 3-4% per year, and with price increases at a similar level, the net effect is flat to slightly positive. We expect an adj. EBITA margin of 8.4% (8.4% Q3'25), as Finland continues to weigh on margins (layoffs at a large customer), and we expect Finland to remain soft in Q3'26e.


Heading towards a stronger '27e

We lower our estimates on the back of the soft data. For ‘27e, we expect sales growth of 5% y-o-y and an adj. EBITA margin of 9.7% (7.9% ‘26e), as we expect next year to be a much stronger year for Prevas.


Trading at historical lows

Prevas is trading at historical lows, at 6-4x ‘27e-‘28e EV/adj. EBITA, ~30% below its historical multiple. Over the past five years, peers have averaged sales growth of ~10% and margins of 8%, compared with 17% and 10% for Prevas. Yet Prevas trades ~40% below the peer average. Recent years have been challenging for consulting firms, with lower demand and price pressure affecting margins and forcing layoffs. This has in turn hurt organic growth, which has been negative for eight consecutive quarters. As utilisation improves and the cost savings come through, we see Prevas well positioned for a stronger ‘27e.